RIKEN   Report issue

Academic/Hospital Phase 4
Founded: Saitama Japan (1917)

Organization Overview

First Clinical Trial
2009
NCT00986063
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 4